Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Dig Dis Sci. 2017 Aug 24;62(10):2728–2743. doi: 10.1007/s10620-017-4707-7

Table 2.

Logistic regression models comparing incidence of symptoms for clopidogrel/Sex/Age in IBS patients

Odds ratio 95% CI p value
Naïve clopidogrel versus no-clopidogrel group 1.4 1.14 1.72 <0.0011
Clopidogrel versus no-clopidogrel (adjusted for Age and Sex) 1.75* 1.42 2.15 <0.0001
Sex differences (Female vs. Male) after adjusting for clopidogrel and Age 1.01 0.90 1.14 0.8356
Age as a continuous variable (adjusted for clopidogrel and Sex) 0.99* 0.98 0.99 <0.0001
Females only
 Clopidogrel versus no-clopidogrel 1.98* 1.55 2.53 <0.0001
 Age 0.98* 0.98 0.99 <0.0001
Males only
 Clopidogrel versus no-clopidogrel 1.18 0.79 1.78 0.4137
 Age 0.99* 0.99 1.00 0.0072

CI confidence interval

*

The difference is significant